• Study of NVG-2089 given by intravenous infusion in patients with immune thrombocytopenia to evaluate safety and effectiveness

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Greece Poland Spain

  • Study of ziltivekimab compared to placebo in patients with acute heart attack to evaluate its effects on coronary artery plaque reduction

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Denmark Italy The Netherlands Spain

  • Study of Everolimus and Resistance Training to Improve Bone Formation in Healthy Postmenopausal Women

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Comparing effectiveness of topical permethrin, oral ivermectin, and their combination for treating patients with confirmed scabies infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study of melphalan followed by trifluridine-tipiracil and bevacizumab combination versus trifluridine-tipiracil and bevacizumab in liver metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Germany Italy The Netherlands Spain

  • Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder

    Recruiting

    3 1 1
    Investigated Drugs:
    Bulgaria Croatia Denmark France Hungary Italy +5

  • Study of Saccharomyces boulardii CNCM I-745 to treat symptoms in adults with non-constipated Irritable Bowel Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Portugal Spain

  • Study of typology-based coaching and education to help patients with early hormone-positive HER2-negative breast cancer manage their treatment with ribociclib

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Germany

  • Study of ivosidenib maintenance treatment in patients with IDH1-mutated cholangiocarcinoma after standard chemotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Finland France Germany Greece +8

powered by